SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial
Recruiting
N/A
Interventional Study
Hypothyroidism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 107 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to find out whether hypothyroidism caused by immune checkpoint inhibitors (ICIs) can recover after stopping the ICIs. The study also aims to identify factors that can help predict which patients will be able to stop taking thyroid hormone replacement.
The main questions the study will answer are:
* What percentage of patients recover normal thyroid function and can stop…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 19 years or older.
* Patients with a history of treatment with immune checkpoint inhibitors (ICIs).
* Developed hypothyroidism during ICI treatment and initiated levothyroxine after starting ICI therapy.
* Discontinued ICI therapy prior to study enrollment.
Exclus…
Contacts